Therapeutic Advances in Psychopharmacology – A New Vision for Mental Health

What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications

Author: Editorial 9th September 2021 0 Comments

Adele Framer has written an article for the journal Therapeutic Advances in Psychopharmacology. The abstract says: “Although psychiatric drug withdrawal syndromes have been recognized since the 1950s – recent studies confirm antidepressant withdrawal syndrome incidence upwards of 40% – medical information…
Read more

collaborative practice

Adele Framer, antidepressants, Clients & Patients, deprescribing, discontinuation syndrome, peer support, psychotropic drugs, tapering, Therapeutic Advances in Psychopharmacology, withdrawal syndrome

Listening to the Patient Voice: The Antidepressant Withdrawal Experience

Author: Editorial 30th August 2021 0 Comments

“’A total of 97% of respondents were offered a prescription on their initial consultation with a doctor, 5% reported being offered talking therapy, and 0.6% were offered lifestyle advice (with some patients offered more than one option).’According to the researchers,…
Read more

collaborative practice

Anne Guy, antidepressant withdrawal, antidepressants, Clients & Patients, Mad in America, Marion Brown, Mark Horowitz, Peter Simons, Research, Stevie Lewis, Therapeutic Advances in Psychopharmacology

Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA

Author: Editorial 20th August 2021 0 Comments

Prof. Peter Gøtzsche has tweeted : “When you stop taking a depression pill and feel bad, psychiatrists tell you that you have relapsed. Not so. By far most, perhaps even all your troubles, are withdrawal symptoms … Never stop abruptly. This…
Read more

collaborative practice

antidepressants, depression, Food & Drug Administration (FDA), Peter Gøtzsche, placebo, prophylactic effects, relapse prevention, Research, Therapeutic Advances in Psychopharmacology, withdrawal confounding